Recombinant Human CUTL1 Protein，GST

CUTL1 (also known as Cux1 or Cut-like homeobox 1) is a transcription factor that plays a crucial role in various biological processes, including development, cellular differentiation, and tumorigenesis. It is a member of the Cut homeobox gene family, which is involved in the regulation of gene expression during developmental stages. Research has increasingly focused on CUTL1 due to its involvement in multiple signaling pathways and its potential link to cancer progression. Abnormal expression of CUTL1 has been observed in various cancers, suggesting it may play a role in oncogenic processes. Moreover, CUTL1 is implicated in the regulation of cell cycle progression and apoptosis, further highlighting its significance in maintaining cellular homeostasis. The use of recombinant protein technology to produce CUTL1 allows for in-depth studies into its structure and function, enabling researchers to explore its mechanisms of action and potential as a therapeutic target. Understanding the role of CUTL1 in cellular contexts can shed light on its potential involvement in diseases and provide insights into novel approaches for cancer treatment and prevention. With advances in protein expression systems, including bacterial, yeast, and mammalian cells, the generation of high-purity CUTL1 recombinant protein facilitates functional assays and structural analyses, which are vital for deciphering its biological activities and interactions within the cellular milieu. Thus, ongoing research into CUTL1 recombinant protein serves as a critical stepping stone toward unraveling its complex functions and therapeutic potentials in oncology and regenerative medicine.